| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JAMCOLLSURG.2008.04.033 |
| P698 | PubMed publication ID | 18926452 |
| P2093 | author name string | Andrew K Stewart | |
| Clifford Y Ko | |||
| David J Bentrem | |||
| Stephen F Sener | |||
| David P Winchester | |||
| Mark S Talamonti | |||
| Karl Y Bilimoria | |||
| Malcolm M Bilimoria | |||
| P433 | issue | 4 | |
| P921 | main subject | pancreaticoduodenectomy | Q1266423 |
| P304 | page(s) | 510-519 | |
| P577 | publication date | 2008-06-30 | |
| P1433 | published in | Journal of the American College of Surgeons | Q15723630 |
| P1476 | title | Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer | |
| P478 | volume | 207 |
| Q26748880 | A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma |
| Q37468883 | Accomplishments in 2008 in the management of localized pancreatic cancer. |
| Q91596825 | Age comorbidity scores as risk factors for 90-day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population-Based Study |
| Q37229551 | Assessment of pancreatic cancer care in the United States based on formally developed quality indicators |
| Q34067852 | Borderline resectable pancreatic cancer: definitions and management |
| Q89184431 | CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis |
| Q36097180 | Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center? |
| Q30726275 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base |
| Q60518255 | Complete Mesocolic Excision—A Marker of Surgical Quality? |
| Q40920175 | Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors |
| Q47716584 | Contemporary Management of Localized Resectable Pancreatic Cancer |
| Q45785395 | Do hospital attributes predict guideline-recommended gastric cancer care in the United States? |
| Q42575074 | Endoscopic treatment of acute biliary diseases: have we optimized the value of inpatient endoscopic retrograde cholangiopancreatography? |
| Q33679661 | Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms |
| Q37131693 | Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer |
| Q36503249 | Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. |
| Q37480826 | Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other) |
| Q26799450 | Imaging preoperatively for pancreatic adenocarcinoma |
| Q53093800 | Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. |
| Q37467860 | Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy |
| Q36175071 | Impact of surgical volume on nationwide hospital mortality after pancreaticoduodenectomy |
| Q34786079 | Institutional clinical trial accrual volume and survival of patients with head and neck cancer |
| Q34538828 | Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy |
| Q38609027 | Investigation and management of pancreatic tumours |
| Q44260131 | Is Illinois heeding the call to regionalize pancreatic surgery? |
| Q90245724 | Local radicality and survival outcome of pancreatic cancer surgery |
| Q37314875 | Lower provider volume is associated with higher failure rates for endoscopic retrograde cholangiopancreatography |
| Q44445741 | Medical-oncological aspects in the treatment of pancreatic cancer |
| Q38171293 | National assessment of margin status as a quality indicator after pancreatic cancer surgery |
| Q92129848 | Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review |
| Q34183257 | Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer |
| Q37252144 | Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. |
| Q53394103 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. |
| Q33679644 | Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion |
| Q84708228 | Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival |
| Q55248840 | Proposal for a structured computed tomography report in the evaluation of pancreatic neoplasms based on expert opinions. |
| Q36767564 | Prostate cancer: Case volume and improved outcomes across cancer care |
| Q35045431 | Quality improvement of pancreatic surgery by centralization in the western part of the Netherlands |
| Q53422328 | Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide. |
| Q89629982 | Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield |
| Q64094411 | Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases |
| Q39938854 | Sociodemographics and comorbidities influence decisions to undergo pancreatic resection for neoplastic lesions |
| Q37702608 | Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma |
| Q42677044 | Surgeon volume plays a significant role in outcomes and cost following open incisional hernia repair |
| Q39054447 | Surgeon, not technique, defines outcomes after central venous port insertion |
| Q33622822 | Surgery residency training programmes have greater impact on outcomes after pancreaticoduodenectomy than hospital volume or surgeon frequency |
| Q53088925 | Survival estimates after pancreatoduodenectomy skewed by non-standardized histopathology reports. |
| Q37866213 | Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. |
| Q49200899 | The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging |
| Q57224786 | The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery |
| Q45042621 | The robotic Whipple: operative strategy and technical considerations. |
| Q28084531 | Use of Radiographic Criteria to Predict Outcomes Following Surgery for Pancreatic Cancer |
Search more.